![Gabriele Cerrone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabriele Cerrone
Gründer bei
ACCM SCIE
Vermögen: 83 Mio $ am 31.05.2026
Profil
Gabriele Marco Antonio Cerrone was the founder of Cardiff Oncology, Inc. (2006, Co-Chairman), FermaVir Pharmaceuticals LLC (2007, Chairman), Synergy Pharmaceuticals LLC (Chairman), Tiziana Life Sciences Ltd. (United Kingdom) (Executive Chairman & Chief Executive Officer), Rasna Therapeutics, Inc. (Chairman), AccuStem Sciences, Inc. (2020, Non-Executive Chairman), Tiziana Life Sciences Ltd. (Executive Chairman).
Mr. Cerrone is also the founder of Hepion Pharmaceuticals, Inc., Arna Therapeutics Ltd., Biovitas Capital Ltd., Gensignia Life Sciences, Inc., Gensignia Ltd. Current jobs include Executive Chairman & Managing Partner at Panetta Partners Ltd. (2013), Non-Executive Chairman at OKYO Pharma Ltd. (2021), Director at Gensignia IP Ltd. (2014).
Former jobs include Chairman at Callisto Pharmaceuticals, Inc. (2003-2013), Director at SIGA Technologies, Inc. (2003), Independent Director at Inhibitex LLC (2011-2012), Director at Pawfect Foods, Inc., Managing Director-Investments at Barrington Capital Group LP (1999), Senior Vice President-Investments at Oppenheimer & Co., Inc. (1999-2005).
Education includes an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 44’654’830 ( 37.57% ) | 63 Mio $ | 31.05.2026 | |
OKYO PHARMA LIMITED 21.08% | 08.06.2026 | 10’826’416 ( 21.08% ) | 19 Mio $ | 31.05.2026 |
| 13.06.2025 | 4’950’355 ( 30.8% ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Gabriele Cerrone
| Unternehmen | Position | Beginn |
|---|---|---|
| WEST AFRICAN MINERALS CORP | Vorsitzender | 07.01.2021 |
| ACCM SCIE | Gründer | 05.06.2020 |
| TIZIANA LIFE SCIENCES LTD | Gründer | 11.02.1998 |
Gensignia IP Ltd.
 Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Direktor/Vorstandsmitglied | 23.04.2014 |
Biovitas Capital Ltd. | Gründer | - |
Arna Therapeutics Ltd.
 Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Gründer | - |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Vorstandsvorsitzender | - |
Panetta Partners Ltd.
 Panetta Partners Ltd. Financial ConglomeratesFinance Private equity firm, primarily for technology companies | Vorsitzender | 12.08.2013 |
Ehemalige bekannte Positionen von Gabriele Cerrone
| Unternehmen | Position | Ende |
|---|---|---|
Gensignia Ltd. | Gründer | 29.04.2014 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Gabriele Cerrone
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
22
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 22 |
|---|---|
SIGA Technologies, Inc.
 SIGA Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines and antibiotics | Health Technology |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Panetta Partners Ltd.
Panetta Partners Ltd. Financial ConglomeratesFinance Private equity firm, primarily for technology companies | Finance |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Pawfect Foods, Inc.
 Pawfect Foods, Inc. Specialty StoresRetail Trade Sells pet food via the internet | Retail Trade |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Barrington Capital Group LP | |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Gensignia Ltd. | |
Arna Therapeutics Ltd.
Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Biovitas Capital Ltd. | |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which develop new molecular diagnosis techniques | Health Technology |
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Develops cancer drugs | Distribution Services |
Gensignia IP Ltd.
Gensignia IP Ltd. Miscellaneous Commercial ServicesCommercial Services Provides professional, scientific and technical services | Commercial Services |
AccuStem Sciences, Inc.
 AccuStem Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomics-based personalized medicines for breast cancer patients | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
